Poxel Reports Revenue for the Third Quarter 2025 [Yahoo! Finance]
SUMITOMO CHEM UNSP/ADR (SOMMY)
NASDAQ:AMEX Investor Relations:
sumitomo-chem.co.jp/english/ir
Company Research
Source: Yahoo! Finance
Gross TWYMEEG ® for Sumitomo Pharma amounted to JPY 5 billion for the first half ended September 30, supporting its full-year forecast of JPY 11.2 billion for the fiscal year ending March 31, 2026 , which would represent a 47% increase compared to fiscal year 2024 sales LYON, France, November 13, 2025 BUSINESS WIRE )--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today reports its revenue for the quarter ended September 30, 2025, and for the first nine months of the fiscal year. Nicolas Trouche, Chief Executive Officer of Poxel , states: "Dear shareholders, as you know, Poxel is in a very difficult situation due to its financial circumstances, which has led us to seek protection from the Economic Affairs Court under a reorganization p
Show less
Read more
Impact Snapshot
Event Time:
SOMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOMMY alerts
High impacting SUMITOMO CHEM UNSP/ADR news events
Weekly update
A roundup of the hottest topics
SOMMY
News
- Valent BioSciences and Seipasa Form Strategic Partnership to Bring Novel Biostimulant Products to the U.S. Market [Yahoo! Finance]Yahoo! Finance
- Valent BioSciences and Seipasa Form Strategic Partnership to Bring Novel Biostimulant Products to the U.S. MarketBusiness Wire
- Sumitomo Chemical Company reports Q2 results [Seeking Alpha]Seeking Alpha
- Taoka Chemical (TSE:4113) Net Margin Surge Challenges Dividend Sustainability Concerns [Yahoo! Finance]Yahoo! Finance
- Valent BioSciences, MGK, and Valent North America Become Sumitomo Biorational Company, a Global Center of Excellence for Biorational InnovationBusiness Wire